Safety assessment of the SGLT2 inhibitors empagliflozin, dapagliflozin and canagliflozin during pregnancy: An ex vivo human placenta perfusion and in vitro study.

Autor: Kuoni S; Department of Obstetrics, University Hospital Zurich, CH-8091 Zurich, Switzerland; University of Zurich, CH-8091 Zurich, Switzerland., Steiner R; Institute of Clinical Chemistry, University Hospital of Zurich, CH-8091 Zurich, Switzerland., Saleh L; Institute of Clinical Chemistry, University Hospital of Zurich, CH-8091 Zurich, Switzerland., Lehmann R; Department of Endocrinology, University Hospital of Zurich, CH-8091 Zurich, Switzerland; University of Zurich, CH-8091 Zurich, Switzerland., Ochsenbein-Kölble N; Department of Obstetrics, University Hospital Zurich, CH-8091 Zurich, Switzerland; University of Zurich, CH-8091 Zurich, Switzerland., Simões-Wüst AP; Department of Obstetrics, University Hospital Zurich, CH-8091 Zurich, Switzerland; University of Zurich, CH-8091 Zurich, Switzerland. Electronic address: anapaula.simoes-wuest@usz.ch.

Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Feb; Vol. 171, pp. 116177. Date of Electronic Publication: 2024 Jan 23.

Transplacental passage of hyperforin, hypericin, and valerenic acid.

Autor: Spiess D; Department of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Abegg VF; Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Chauveau A; Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Rath J; Department of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Treyer A; Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Reinehr M; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., Kuoni S; Department of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Oufir M; Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Potterat O; Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Hamburger M; Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Simões-Wüst AP; Department of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2023 Mar 31; Vol. 14, pp. 1123194. Date of Electronic Publication: 2023 Mar 31 (Print Publication: 2023).

Implications of pregnancy on cardiometabolic disease risk: preeclampsia and gestational diabetes.

Autor: Elgazzaz, Mona, Woodham, Padmashree C., Maher, James, Faulkner, Jessica L.

Publikováno v: American Journal of Physiology: Cell Physiology; Sep2024, Vol. 327 Issue 3, pC646-C660, 15p

Cellular neurobiology of hyperforin.

Autor: Bouron A; Université Grenoble Alpes, CNRS, CEA, Inserm UA13 BGE, Grenoble, France.

Publikováno v: Phytotherapy research : PTR [Phytother Res] 2024 Feb; Vol. 38 (2), pp. 636-645. Date of Electronic Publication: 2023 Nov 14.

6325 SAYILI KANUN İLE ÖNGÖRÜLEN DAVA AÇMA YASAĞININ BİR İSTİSNASI OLARAK ARABULUCULUK ANLAŞMA BELGESİNİN İPTALİ. (Turkish)

Autor: BAŞ, Seda

Publikováno v: Inonu University Law Review / İnönü Üniversitesi Hukuk Fakültesi Dergisi; oca-haz2022, Vol. 13 Issue 1, p176-189, 14p